The Access to COVID-19 Tools Accelerator (ACT-A) was launched in April 2020 with the aim of accelerating development, production, and equitable access to COVID-19 tests, treatments, and vaccines. ACT-A brings together governments, scientists, businesses, civil society, philanthropists and global health organizations. UNICEF plays a substantial role in all three ACT-A pillars (diagnostics, therapeutics and vaccines), and in the Health Systems connector.

The incumbent will lead health economic activities for UNICEF activities within the three ACT-A pillars and the Health Systems connector. The work entails providing data and evidence on costs and financing of ACT-A interventions. Activities range from providing global level cost estimates to support fundraising efforts to designing and managing health economic implementation research studies.